Literature DB >> 27665705

Comparison of the diagnostic power of cytokine patterns and procalcitonin for predicting infection among paediatric haematology/oncology patients.

T Xia1, X Xu1, N Zhao1, Z Luo2, Y Tang3.   

Abstract

OBJECTIVES: To evaluate the diagnostic power of the cytokine patterns and serum procalcitonin (PCT) level for predicting infection in paediatric haematology-oncology patients.
METHODS: Retrospective study including hospitalized children with haematology-oncology disease was conducted and their serum T helper type 1/type 2 cytokines were measured by a flow cytometric method. According to clinical symptoms, imaging and microbiological findings, febrile episodes were divided into five diagnostic groups serving as reference standard; and also grouped according to disease severity. A control group consisted of afebrile children.
RESULTS: A total of 3023 samples (2819 febrile episodes and 204 control samples) derived from 992 children (including 164 afebrile control patients) were obtained. Interleukin-6 (IL-6) and IL-10 levels as well as their positivity rates were significantly higher among children with bacteraemia than for the viral infection and control groups. Among children with bacteraemia, 92.8% (297/320) and 82.2% (263/320) had increased IL-6 and IL-10 levels that exceeded the upper limit of the normal range, respectively. The positivity rates of PCT and C-reactive protein were only 33.8% (108/320) and 73.1% (234/320), respectively, significantly lower than those of IL-6 and IL-10 (p <0.01). Based on the receiver operating characteristic curves, PCT exhibited poorer sensitivity in the diagnosis of severe infection compared with IL-6 and IL-10 (p <0.01). Specificity of IL-6 and IL-10 was significantly higher than that of PCT in the diagnosis of Gram-negative bacteraemia.
CONCLUSION: Cytokine patterns of IL-6 and IL-10 showed higher diagnostic accuracy than PCT for bacteraemia and severe infections among febrile children with haematology/oncology disease. Copyright Â
© 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Cytokine; Haematology/oncology; Infection; Procalcitonin

Mesh:

Substances:

Year:  2016        PMID: 27665705     DOI: 10.1016/j.cmi.2016.09.013

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  13 in total

1.  Febrile illness in high-risk children: a prospective, international observational study.

Authors:  Fabian J S van der Velden; Gabriella de Vries; Alexander Martin; Emma Lim; Ulrich von Both; Laura Kolberg; Enitan D Carrol; Aakash Khanijau; Jethro A Herberg; Tisham De; Rachel Galassini; Taco W Kuijpers; Federico Martinón-Torres; Irene Rivero-Calle; Clementien L Vermont; Nienke N Hagedoorn; Marko Pokorn; Andrew J Pollard; Luregn J Schlapbach; Maria Tsolia; Irini Elefhteriou; Shunmay Yeung; Dace Zavadska; Colin Fink; Marie Voice; Werner Zenz; Benno Kohlmaier; Philipp K A Agyeman; Effua Usuf; Fatou Secka; Ronald de Groot; Michael Levin; Michiel van der Flier; Marieke Emonts
Journal:  Eur J Pediatr       Date:  2022-10-15       Impact factor: 3.860

2.  Combination of C-reactive protein, procalcitonin, IL-6, IL-8, and IL-10 for early diagnosis of hyperinflammatory state and organ dysfunction in pediatric sepsis.

Authors:  Gongbo Zeng; Dong Chen; Renxi Zhou; Xinfeng Zhao; Cuiying Ye; Huiting Tao; Wenbin Sheng; Yidong Wu
Journal:  J Clin Lab Anal       Date:  2022-05-27       Impact factor: 3.124

3.  Diagnostic Accuracy of Procalcitonin Compared to C-Reactive Protein and Interleukin 6 in Recognizing Gram-Negative Bloodstream Infection: A Meta-Analytic Study.

Authors:  Liying Lai; Yijie Lai; Hao Wang; Liang Peng; Ning Zhou; Yi Tian; Yongfang Jiang; Guozhong Gong
Journal:  Dis Markers       Date:  2020-01-23       Impact factor: 3.434

4.  One-incubation one-hour multiplex ELISA enabled by aqueous two-phase systems.

Authors:  Mintra Tongdee; Cameron Yamanishi; Midori Maeda; Taisuke Kojima; John Dishinger; Rattikan Chantiwas; Shuichi Takayama
Journal:  Analyst       Date:  2020-05-18       Impact factor: 4.616

5.  Diagnostic Accuracy of Immunologic Biomarkers for Accurate Diagnosis of Bloodstream Infection in Patients with Malignancy: Procalcitonin in Comparison with C-Reactive Protein.

Authors:  Mansoureh Shokripour; Navid Omidifar; Kourosh Salami; Mohsen Moghadami; Babak Samizadeh
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-10-31       Impact factor: 2.471

6.  The clinical outcomes and biomarker features of severe sepsis/septic shock with severe neutropenia: a retrospective cohort study.

Authors:  Fan Yin; Yue-Ling Xi; Ying Wang; Bi-Ru Li; Juan Qian; Hong Ren; Jian Zhang; Hong-Zhi Tang; Bo-Tao Ning
Journal:  Transl Pediatr       Date:  2021-03

7.  Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies.

Authors:  Zengzheng Li; Zefeng Yang; Peng Hu; Xin Guan; Lihua Zhang; Jinping Zhang; Tonghua Yang; Chaoran Zhang; Renbin Zhao
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

8.  Biomarkers for Diagnosing Febrile Illness in Immunocompromised Children: A Systematic Review of the Literature.

Authors:  Fabian J S van der Velden; Andrew R Gennery; Marieke Emonts
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418

9.  Diagnostic Accuracy of Plasma Ghrelin Concentrations in Pediatric Sepsis-Associated Acute Respiratory Distress Syndrome: A Single-Center Cohort Study.

Authors:  Xiu Yuan; Shaojun Li; Liang Zhou; Tian Tang; Yuwei Cheng; Xiaoxiao Ao; Liping Tan
Journal:  Front Pediatr       Date:  2021-05-21       Impact factor: 3.418

10.  Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia.

Authors:  Marcel Doerflinger; Gabrielle M Haeusler; Connie S N Li-Wai-Suen; Julia E Clark; Monica Slavin; Franz E Babl; Zoe Allaway; Francoise Mechinaud; Gordon K Smyth; Richard De Abreu Lourenco; Bob Phillips; Marc Pellegrini; Karin A Thursky
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.